These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Genetic dissection of the Mom5 modifier locus and evaluation of Mom5 candidate genes. Otterpohl KL; Gould KA Mamm Genome; 2015 Jun; 26(5-6):235-47. PubMed ID: 25976411 [TBL] [Abstract][Full Text] [Related]
43. Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis. Roberts RB; Min L; Washington MK; Olsen SJ; Settle SH; Coffey RJ; Threadgill DW Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1521-6. PubMed ID: 11818567 [TBL] [Abstract][Full Text] [Related]
44. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Oshima M; Oshima H; Kitagawa K; Kobayashi M; Itakura C; Taketo M Proc Natl Acad Sci U S A; 1995 May; 92(10):4482-6. PubMed ID: 7753829 [TBL] [Abstract][Full Text] [Related]
45. Reduction in alkaline sphingomyelinase in colorectal tumorigenesis is not related to the APC gene mutation. Hertervig E; Nilsson A; Nilbert M; Duan RD Int J Colorectal Dis; 2003 Jul; 18(4):309-13. PubMed ID: 12774245 [TBL] [Abstract][Full Text] [Related]
46. Insulin-like growth factor II supply modifies growth of intestinal adenoma in Apc(Min/+) mice. Hassan AB; Howell JA Cancer Res; 2000 Feb; 60(4):1070-6. PubMed ID: 10706126 [TBL] [Abstract][Full Text] [Related]
47. APC in the regulation of intestinal crypt fission. Wasan HS; Park HS; Liu KC; Mandir NK; Winnett A; Sasieni P; Bodmer WF; Goodlad RA; Wright NA J Pathol; 1998 Jul; 185(3):246-55. PubMed ID: 9771477 [TBL] [Abstract][Full Text] [Related]
48. Inactivation of both APC alleles in human and mouse tumors. Levy DB; Smith KJ; Beazer-Barclay Y; Hamilton SR; Vogelstein B; Kinzler KW Cancer Res; 1994 Nov; 54(22):5953-8. PubMed ID: 7954428 [TBL] [Abstract][Full Text] [Related]
49. Strain differences of rats in the susceptibility to aberrant crypt foci formation by 2-amino-1-methyl-6-phenylimidazo- [4,5-b]pyridine: no implication of Apc and Pla2g2a genetic polymorphisms in differential susceptibility. Ishiguro Y; Ochiai M; Sugimura T; Nagao M; Nakagama H Carcinogenesis; 1999 Jun; 20(6):1063-8. PubMed ID: 10357789 [TBL] [Abstract][Full Text] [Related]
50. Lack of phospholipase A2 mutations in neuroblastoma, melanoma and colon-cancer cell lines. Haluska FG; Thiele C; Goldstein A; Tsao H; Benoit EP; Housman D Int J Cancer; 1997 Jul; 72(2):337-9. PubMed ID: 9219842 [TBL] [Abstract][Full Text] [Related]
51. The genetic background of familial adenomatous polyposis. Linkage analysis, the APC gene identification and mutation screening. Kartheuser A; West S; Walon C; Curtis A; Hamzehloei T; Lannoy N; Michiels G; Smaers M; Chapman P; Burn J Acta Gastroenterol Belg; 1995; 58(5-6):433-51. PubMed ID: 8776001 [TBL] [Abstract][Full Text] [Related]
52. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis. Li Q; Ishikawa TO; Oshima M; Taketo MM Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028 [TBL] [Abstract][Full Text] [Related]
53. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine increases the numbers of tumors, cystic crypts and aberrant crypt foci in multiple intestinal neoplasia mice. Steffensen IL; Paulsen JE; Eide TJ; Alexander J Carcinogenesis; 1997 May; 18(5):1049-54. PubMed ID: 9163695 [TBL] [Abstract][Full Text] [Related]
54. SPLASH (PLA2IID), a novel member of phospholipase A2 family, is associated with lymphotoxin deficiency. Shakhov AN; Rubtsov AV; Lyakhov IG; Tumanov AV; Nedospasov SA Genes Immun; 2000 Feb; 1(3):191-9. PubMed ID: 11196711 [TBL] [Abstract][Full Text] [Related]
55. Impact of Phospholipase A2 group IIa gene polymorphism on phenotypic features of patients with familial adenomatous polyposis. Yanaru-Fujisawa R; Matsumoto T; Kukita Y; Nakamura S; Yao T; Hayashi K; Iida M Dis Colon Rectum; 2007 Feb; 50(2):223-31. PubMed ID: 17164967 [TBL] [Abstract][Full Text] [Related]
56. Polyclonality of familial murine adenomas: analyses of mouse chimeras with low tumor multiplicity suggest short-range interactions. Thliveris AT; Halberg RB; Clipson L; Dove WF; Sullivan R; Washington MK; Stanhope S; Newton MA Proc Natl Acad Sci U S A; 2005 May; 102(19):6960-5. PubMed ID: 15870186 [TBL] [Abstract][Full Text] [Related]
57. Cloning and cellular distribution of a group II phospholipase A2 expressed in the heart. De Windt LJ; Willemsen PH; Pöpping S; Van der Vusse GJ; Reneman RS; Van Bilsen M J Mol Cell Cardiol; 1997 Aug; 29(8):2095-106. PubMed ID: 9281442 [TBL] [Abstract][Full Text] [Related]
58. Identification of novel modifier loci of Apc Min affecting mammary tumor development. Wang H; Teske D; Tess A; Kohlhepp R; Choi Y; Kendziorski C; Moser AR Cancer Res; 2007 Dec; 67(23):11226-33. PubMed ID: 18056448 [TBL] [Abstract][Full Text] [Related]
59. Apc mice: models, modifiers and mutants. McCart AE; Vickaryous NK; Silver A Pathol Res Pract; 2008; 204(7):479-90. PubMed ID: 18538487 [TBL] [Abstract][Full Text] [Related]
60. Absence of secretory phospholipase A2 gene alterations in human colorectal cancer. Riggins GJ; Markowitz S; Wilson JK; Vogelstein B; Kinzler KW Cancer Res; 1995 Nov; 55(22):5184-6. PubMed ID: 7585570 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]